UK markets close in 7 hours 38 minutes
  • FTSE 100

    7,019.85
    +36.35 (+0.52%)
     
  • FTSE 250

    22,549.29
    +77.25 (+0.34%)
     
  • AIM

    1,249.61
    +1.48 (+0.12%)
     
  • GBP/EUR

    1.1470
    -0.0041 (-0.35%)
     
  • GBP/USD

    1.3743
    -0.0041 (-0.30%)
     
  • BTC-GBP

    44,909.95
    -1,142.83 (-2.48%)
     
  • CMC Crypto 200

    1,371.13
    -9.82 (-0.71%)
     
  • S&P 500

    4,170.42
    +45.76 (+1.11%)
     
  • DOW

    34,035.99
    +305.10 (+0.90%)
     
  • CRUDE OIL

    63.72
    +0.26 (+0.41%)
     
  • GOLD FUTURES

    1,763.70
    -3.10 (-0.18%)
     
  • NIKKEI 225

    29,683.37
    +40.68 (+0.14%)
     
  • HANG SENG

    29,009.12
    +215.98 (+0.75%)
     
  • DAX

    15,319.16
    +63.83 (+0.42%)
     
  • CAC 40

    6,251.62
    +17.48 (+0.28%)
     

Artificial Intelligence in Healthcare Diagnosis Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Diagnostic Tool ; Application ; End User ; Service ; and Geography

ReportLinker
·3-min read

The artificial intelligence (AI) in healthcare diagnosis market was valued at US$ 3,639. 02 million in 2019 and is projected to reach US$ 66,811. 97 million by 2027; it is expected to grow at a CAGR of 44.

New York, March 24, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Artificial Intelligence in Healthcare Diagnosis Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Diagnostic Tool ; Application ; End User ; Service ; and Geography" - https://www.reportlinker.com/p05932654/?utm_source=GNW
0% during 2020–2027. The growth of the market is mainly attributed to factors such rising adoption of AI in disease identification and diagnosis, and increasing investments in AI healthcare startups. However, the lack of skilled workforce and ambiguity in regulatory guidelines for medical software are the factor hindering the growth of the market.

Artificial Intelligence in healthcare is one of the most significant technological advancements in medicine so far.The involvement of multiple startups in the development of AI-driven imaging and diagnostic solutions is the major factors contributing to the growth of the market.

China, the US, and the UK are emerging as popular hubs for healthcare innovations.Additionally, the British government has announced the establishment of a National Artificial Intelligence Lab that would collaborate with the country’s universities and technology companies to conduct research on cancer, dementia, and heart diseases.

The UK-based startups have received benefits from the government’s robust library of patient data, as British citizens share their anonymous healthcare data with the British National Health Service. As a result, the number of artificial intelligence startups in the healthcare sector has significantly grown in the past few years, and the trend is expected to be the same in the coming years.

Based on diagnostic tool, the global artificial intelligence in healthcare diagnosis market is segmented into medical imaging tool, automated detection system, and others. The medical imaging tool segment held the largest share of the market in 2019, and the market for automated detection system is expected to grow at the highest CAGR during the forecast period.

Based on application, the global artificial intelligence in healthcare diagnosis market is segmented into eye care, oncology, radiology, cardiovascular, and others. The oncology segment held the larger share of the market in 2019, and the radiology segment is expected to register the highest CAGR during the forecast period.

Based on service, the global artificial intelligence in healthcare diagnosis market is segmented into tele-consultation, tele monitoring, and others. The tele-consultation segment held the largest share of the market in 2019, however, tele monitoring segment it is further expected to report the highest CAGR in the market during the forecast period.

Based on end user, the global artificial intelligence in healthcare diagnosis market is segmented into hospital and clinic, diagnostic laboratory, and home care. The hospital and clinic segment held the highest share of the market in 2019 and is expected to register the highest CAGR in the market during the forecast period.

The Computer Science and Artificial Intelligence Laboratory (CSAIL), Food and Drug Administration (FDA), National Institute of Health (NIH), and European Medical Association are a few of the major secondary sources referred to while preparing this report.
Read the full report: https://www.reportlinker.com/p05932654/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001